Insider · CIK 0001363683
Peter Greenleaf
Files at AUPH (Aurinia Pharmaceuticals Inc.), PTHS (Channel Therapeutics Corp). First filing Mar 4, 2025, latest Oct 6, 2026.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
PTHS: Channel Therapeutics Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
AUPH: Aurinia Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | Channel Therapeutics Corp | $17k 797 shares | -3% | - | |
| 70Notable | Aurinia Pharmaceuticals Inc. | $2.9M 360,540 shares | -17% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | PTHS Channel Therapeutics Corp | SOpen-market sale Common Stock10b5-1 | -797 | $21.17 | $17k | 23,087 | 6 d ago |
| Feb 28, 2025 | AUPH Aurinia Pharmaceuticals Inc. | AGrant or award Common Stock | +290,728 | $0.00 | $0 | 1,815,780 | Mar 4, 2025 |
| Mar 3, 2025 | AUPH Aurinia Pharmaceuticals Inc. | AGrant or award Common Stock | +333,705 | $0.00 | $0 | 2,149,485 | Mar 4, 2025 |
| Mar 3, 2025 | AUPH Aurinia Pharmaceuticals Inc. | SOpen-market sale Common Stock | -195,593 | $8.00 | $1.6M | 1,953,892 | Mar 4, 2025 |
| Mar 4, 2025 | AUPH Aurinia Pharmaceuticals Inc. | SOpen-market sale Common Stock | -164,947 | $7.92 | $1.3M | 1,788,945 | Mar 4, 2025 |
| Feb 28, 2025 | AUPH Aurinia Pharmaceuticals Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +443,973 | $0.00 | $0 | 443,973 | Mar 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.